S. Koreas biotech sector kicks off 2025 with multi-billion-dollar deals K-Bio firms secure nearly $2.3 billion in licensing ...

Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by adding four more locations this year, along with 13,000 high-wage jobs.

Another big pharma in the RNA business is Eli Lilly, which has been spending quite the penny on partnerships lately. Its collaboration with South Korean biotech OliX is to develop and commercialize ...

Chang later returned home on the same road where hours earlier he’d hit Lilly Glaubach. He spent one more night with his wife and daughter before police knocked on his door after a Good ...

A small Swiss biotech has ter­mi­nat­ed a mid-stage test of a new type of oral drug for peo­ple with Alzheimer’s dis­ease, ac­cord­ing to the fed­er­al … ...

Eli Lilly has launched new 7.5 mg and 10 mg single-dose vials of Zepbound (tirzepatide), priced at $499 per month under the newly introduced Zepbound Self Pay Journey Program. The company said ...

The "Nosferatu" star's dress is based on a 1995 runway look. Lily-Rose Depp channeled the gothic vibe of her "Nosferatu" character, Ellen Hutter, in a black lace dress on the Oscars red carpet on ...

Eli Lilly (NYSE:LLY) recently announced its plans to invest $27 billion in four new U.S. manufacturing plants over the next five years, creating thousands of jobs. This move comes at a time when ...

Credit: shisu_ka/Shutterstock. Magnet Biomedicine has entered a partnership and licence agreement with Eli Lilly to discover, develop and commercialise oncology molecular glue therapeutics. The ...

It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. The company has been one of the best-performing pharmaceutical giants, with its shares ...

Eli Lilly is set to keep growing its revenue at a strong pace in the next five years. The company is likely to add important medicines to its lineup. Eli Lilly's shares look attractive right now.

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...